WO2002053030A1 - Procede et dispositif pour evaluer l'etat physiologique de l'organisme humain - Google Patents
Procede et dispositif pour evaluer l'etat physiologique de l'organisme humain Download PDFInfo
- Publication number
- WO2002053030A1 WO2002053030A1 PCT/RU2001/000007 RU0100007W WO02053030A1 WO 2002053030 A1 WO2002053030 A1 WO 2002053030A1 RU 0100007 W RU0100007 W RU 0100007W WO 02053030 A1 WO02053030 A1 WO 02053030A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- potassium
- saliva
- sensor
- diffuse
- human
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 15
- 230000035790 physiological processes and functions Effects 0.000 title abstract 2
- 229910052700 potassium Inorganic materials 0.000 claims abstract description 22
- 239000011591 potassium Substances 0.000 claims abstract description 22
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims abstract description 21
- 210000003296 saliva Anatomy 0.000 claims abstract description 21
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 8
- 239000011575 calcium Substances 0.000 claims description 8
- 229910052791 calcium Inorganic materials 0.000 claims description 8
- 150000002500 ions Chemical class 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 4
- 230000008859 change Effects 0.000 claims description 3
- 210000003608 fece Anatomy 0.000 claims description 3
- 230000006866 deterioration Effects 0.000 claims description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims 2
- 230000004907 flux Effects 0.000 claims 1
- 235000011164 potassium chloride Nutrition 0.000 claims 1
- 239000001103 potassium chloride Substances 0.000 claims 1
- 239000007784 solid electrolyte Substances 0.000 claims 1
- 239000011734 sodium Substances 0.000 abstract description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract description 4
- 238000009792 diffusion process Methods 0.000 abstract description 3
- BITYAPCSNKJESK-UHFFFAOYSA-N potassiosodium Chemical compound [Na].[K] BITYAPCSNKJESK-UHFFFAOYSA-N 0.000 abstract description 3
- 239000007787 solid Substances 0.000 abstract description 2
- 239000011521 glass Substances 0.000 abstract 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 abstract 1
- 238000003969 polarography Methods 0.000 abstract 1
- 229910001414 potassium ion Inorganic materials 0.000 abstract 1
- 229910001415 sodium ion Inorganic materials 0.000 abstract 1
- 230000008569 process Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- ZDHURYWHEBEGHO-UHFFFAOYSA-N potassiopotassium Chemical compound [K].[K] ZDHURYWHEBEGHO-UHFFFAOYSA-N 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 241001663154 Electron Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 208000028659 discharge Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000004996 female reproductive system Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 125000002635 lutein group Chemical group 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
- A61B10/0051—Devices for taking samples of body liquids for taking saliva or sputum samples
Definitions
- the invention is subject to diagnostic
- the prevailing level of the tire 10 is known that the increase in the concentration of sodium and potassium in saliva serves as a reliable method of revealing P ⁇ i dis ⁇ un ⁇ tsiya ⁇ in ⁇ ganizme chel ⁇ ve ⁇ a s ⁇ n ⁇ shenie ⁇ ntsen ⁇ atsy na ⁇ iya and ⁇ aliya 'saliva chel ⁇ ve ⁇ a izmenyae ⁇ sya znachi ⁇ eln ⁇ ⁇ anshe than d ⁇ ugi ⁇ bi ⁇ l ⁇ giches ⁇ i ⁇ zhid ⁇ s ⁇ ya ⁇ .
- Hydrochloric acid is a source of saline acid, which is a part of the gastric system. Thanks a lot to iron, it can be trapped in acid. Unresponsiveness causes
- Potassium is indispensable for the liver, spleen, intestine, which helps in the passage of fat and fat. Potassium is indispensable for the cultivation of musculature, it improves circulation of the blood, 5 accelerates the activity of the heart. The lack of energy reduces the mental activity of a person, leads to friendship and inflexibility of musculosities.
- the natu- ral content of sodium and potassium in saliva can serve as a valuable diagnostic test for women with infertility, being an indicator
- the optimal ratio of potassium-potassium in the human body is 1:20, which complies with 3 In relation to the increase in the concentration of potassium and potassium in saliva, an approximate value of 0.6.
- the objective of the invention is the creation of a simple and reliable means of evaluating the physical business of a human being. 4 sodium potassium with saliva using a simple device, as well as the creation of such a device.
- the posed problem is solved by the fact that in the process of evaluating the physiological situation
- a device for evaluating the physiological relations of a human body which contains a sensor in the form of a round, flat-discharged cell from a diet
- the method of consent to the invention is based on measuring the diffuse current with the use of solid electrical appliances.
- the magnitude of the diffuse flow 5 is directly related to the concentration of diffused substances in conjunction with
- ⁇ is the thickness of the effective layer, which depends on the temperature, ⁇ is the number of elec- trons included in the reaction
- a electrical sensor was developed, at a rate of 5, due to an electrical failure, the power supply was not detected. Therefore, it is possible to increase the size of the diffuse flow rate for hot potassium, which is more of a negative material.
- a double measurement of diffuse current is carried out. First, the total diffuse flow rate of sodium and calcium is measured in the two-mode operation of the sensor, and then, after the measurement, the diffuse flow rate is measured
- Sensor 1 is configured to operate in the electrical mode and in the dual electrical mode. In this case, for the production of a two-mode electrical mode of comparison 3 and an optional
- the declared method 5 there is a double measurement of diffuse flow.
- the total diffuse flow of ions and calcium is measured, which corresponds to the total concentration of ions and calcium, after that, the treatment is performed.
- ⁇ a ⁇ ig. 4 An example of the use of a device diagram for the determination of physiological devices is shown. 9 of the human body are according to the invention. Sensor 1 is connected to the switch 5 of the mode of operation of the sensor, which, in turn, through amplifier 6, the electrical connection is connected to 5 divider 7, sensor 1 is also connected to signal 8. The outputs of sensor 1, amplifier 6 are the mains of comparison, divider 7 and signal amplifier 8 are connected to the test unit, made in the form of a microcontroller 9,
- liquid industrial indicator 10 The power supply is supplied with a source of 11 voltage and a source of 12 voltage.
- the current appearance of the device is as shown in FIG. 5.
- the device is made in the form of
- the front panel is equipped with sensor 1, a liquid-crystal indicator 10 and button 14.
- the device operates the following way.
- the device By pressing the button 14, the device is activated. In Sack 1, human saliva is placed. At first, sensor 1 in the two-mode operation is transmitted to the microcontroller 9, the data of the measurements of the total diffuse flow of ions of the
- the proposed facility and facilities of the division 10 are physiological. s ⁇ s ⁇ yaniya ⁇ ganizma chel ⁇ ve ⁇ a ⁇ u ⁇ em ⁇ edeleniya s ⁇ n ⁇ sheniya na ⁇ y- ⁇ aly saliva chel ⁇ ve ⁇ a ⁇ ivle ⁇ ayu ⁇ ⁇ s ⁇ y and v ⁇ zm ⁇ zhn ⁇ s ⁇ yu vy ⁇ lneniya izme ⁇ eny ne ⁇ g ⁇ anichenn ⁇ e chisl ⁇ ⁇ az, ⁇ i e ⁇ m for issled ⁇ vaniya ele ⁇ li ⁇ v 15 saliva not ⁇ ebue ⁇ sya s ⁇ etsialny ⁇ usl ⁇ vy and ⁇ avmi ⁇ uyuschi ⁇ people mani ⁇ ulyatsy.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Optics & Photonics (AREA)
- Biophysics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/RU2001/000007 WO2002053030A1 (fr) | 2001-01-05 | 2001-01-05 | Procede et dispositif pour evaluer l'etat physiologique de l'organisme humain |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/RU2001/000007 WO2002053030A1 (fr) | 2001-01-05 | 2001-01-05 | Procede et dispositif pour evaluer l'etat physiologique de l'organisme humain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2002053030A1 true WO2002053030A1 (fr) | 2002-07-11 |
Family
ID=20129593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/RU2001/000007 WO2002053030A1 (fr) | 2001-01-05 | 2001-01-05 | Procede et dispositif pour evaluer l'etat physiologique de l'organisme humain |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2002053030A1 (fr) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992016842A1 (fr) * | 1991-03-12 | 1992-10-01 | La Mina Ltd. | Procede et dispositif d'essai a la salive et d'identification par empreintes digitales |
| RU2128943C1 (ru) * | 1998-04-09 | 1999-04-20 | Беркенгейм Михаил Леонидович | Способ определения периода овуляции и устройство для его осуществления |
-
2001
- 2001-01-05 WO PCT/RU2001/000007 patent/WO2002053030A1/fr active Application Filing
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992016842A1 (fr) * | 1991-03-12 | 1992-10-01 | La Mina Ltd. | Procede et dispositif d'essai a la salive et d'identification par empreintes digitales |
| RU2128943C1 (ru) * | 1998-04-09 | 1999-04-20 | Беркенгейм Михаил Леонидович | Способ определения периода овуляции и устройство для его осуществления |
Non-Patent Citations (3)
| Title |
|---|
| A.M. PROKHOROVA: "Bolshaya sobetskaya entsiklopediya", 1974, SOVETSKAYA ENTSIKLOPEDIYA, TRETE IZDANIE, MOSCOW * |
| A.M. PROKHOROVA: "Bolshaya sobetskaya entsiklopediya", 1976, SOVETSKAYA ENTSIKLOPEDIYA, TRETE IZDANIE, MOSCOW * |
| A.M. PROKHOROVA: "Bolshaya sovetskaya entsiklopediya", 1977, SOVETSKAYA ENTSIKLOPEDIYA, TRETE IZDANIE, MOSCOW * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5834319B2 (ja) | 酸化還元電位を測定するための装置 | |
| CA2566966C (fr) | Methode de sortie sonore d'un element d'information dans un systeme d'analyse | |
| US20130274566A1 (en) | Moisture meter | |
| JPWO2007123245A1 (ja) | 尿中1日排泄量測定方法及び尿中1日排泄量測定装置 | |
| US20160341693A1 (en) | Multiple layer gel | |
| Davis et al. | Bioelectrical impedance phase angle changes during hydration and prognosis in advanced cancer | |
| JP2001204704A (ja) | 設定及び表示認識を簡易にした生体測定装置 | |
| JP4154884B2 (ja) | 酸化還元電位測定装置および方法 | |
| CN115886725A (zh) | 体液检测装置及检测系统 | |
| WO2002053030A1 (fr) | Procede et dispositif pour evaluer l'etat physiologique de l'organisme humain | |
| CN115639261A (zh) | 体液检测装置和检测方法 | |
| RU7297U1 (ru) | Устройство для определения функционального состояния биологически активных точек тела человека | |
| RU5730U1 (ru) | Устройство для оценки эффективности слабоэнергетического воздействия на биообъект | |
| SU762850A1 (ru) | СПОСОБ ДИАГНОСТИКИ ТКАНЕЙ ЗУБОВ 1' РАЗРУШЕНИЯ / » Г Г" 1 | |
| JPS5917328A (ja) | アプライトキネシロジー用診断装置 | |
| HK1188823A (en) | Apparatus for measuring oxidation-reduction potential |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |